LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $22,364,766

Key CONT_AWD_75N91022F00019_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 99 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91022F00019_7529_75N91019D00024_7529

At the source https://www.usaspending.gov/award/CONT_AWD_75N91022F00019_7529_75N91019D00024_7529

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:54:46Z

Content hash 60c1f649c59a82c85da1296e2a742e5adc205a6bce88ab161a1562f37ec373f9

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$22,364,766	first version	September 8, 2022	May 29, 2026	2026-09-05T00:54:46Z	historical sweep	`60c1f649c59a`

Archived copy

https://web.archive.org/web/20261011114249/https://www.usaspending.gov/award/CONT_AWD_75N91022F00019_7529_75N91019D00024_7529 captured by this system, October 11, 2026

What the amount is made of

3 recorded actions, so the amount is the award's current total across all of them. 1 of them obligated money. Measured 2026-10-12, when USAspending reported a total obligation of $22,364,766.

Action date	Modification	Type	Obligated	Description as recorded
May 29, 2026	P00002	SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE	no money	DISCOVERY AND DEVELOPMENT OF CANCER THERAPEUTICS FOR NEXT PROGRAM
January 13, 2026	P00001	OTHER ADMINISTRATIVE ACTION	no money	DISCOVERY AND DEVELOPMENT OF CANCER THERAPEUTICS FOR NEXT PROGRAM
September 8, 2022	base	not on file	+$22,364,766	DISCOVERY AND DEVELOPMENT OF CANCER THERAPEUTICS FOR NEXT PROGRAM

Last refreshed November 4, 2026 at 2:31 PM UTC.